You are here

  • Home
  • Archive
  • Volume 34, Issue 3
  • Update on near infrared imaging technology: indocyanine green and near infrared technology in the treatment of gynecologic cancers

Article Text

Article menu
Download PDFPDF
Review
Update on near infrared imaging technology: indocyanine green and near infrared technology in the treatment of gynecologic cancers

https://doi.org/10.1136/ijgc-2023-004583

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    You do not have access to the full text of this article, the first page of the PDF of this article appears above.

    Footnotes

    • Twitter @VanceBroach, @leitaomd

    • Contributors All authors have contributed to the conception and design; analysis and interpretation of data; drafting of the manuscript; revising the manuscript critically for important intellectual content; and final approval of the version to be published. All authors also agree to be accountable for all aspects of the work.

    • Funding This study was funded by National Cancer Institute (P30 CA008748).

    • Competing interests NRA-R reports research funding from GRAIL paid to Memorial Sloan Kettering Cancer Center (MSK). MSK also has equity in GRAIL. AO is founder and managing director of SurgicalPerformance. ML reports consulting fees from Medtronic, speaker fees from Intuitive Surgical, and advisory board fees from J&J Ethicon and Immunogen.

    • Provenance and peer review Commissioned; externally peer reviewed.

    Linked Articles